Takeda Pharmaceutical, 10% Owner of Ovid Therapeutics OVID, has filed 0 purchases and 1 sale on the open market. The latest trade was on 25/12/08.

Takeda Pharmaceutical

10% Owner

Company

Ovid Therapeutics OVID

First filing

23/05/26

Trades

5 trades

Buys / sales

0 / 1

12-month net buying

No record

Last trade

25/12/08

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Phathom PharmaceuticalsPHAT	Open-market sale	24/01/24	24/01/25	3,703,703 sh	$8.10	$29,999,994.3	−49.7%